Glucotrack’s Lōkahi Therapeutics Announces University Of Alabama’s Culverhouse College Of Business Will Continue Its Participation In ai² Pipeline Division For Upcoming Academic Year
Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (NASDAQ:GCTK), today announced that The University of Alabama’s Culverhouse College of Business will continue its participation in the ai² Pipeline division for the